OpenURL Connection Search

Select item for more details and to access through your institution.

Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response.
Published in:
2011
By:
- Furusyo N;
- Murata M;
- Ogawa E;
- Toyoda K;
- Ihara T;
- Ikezaki H;
- Hayashi T;
- Koga T;
- Kainuma M;
- Hayashi J;
- Furusyo, Norihiro;
- Murata, Masayuki;
- Ogawa, Eiichi;
- Toyoda, Kazuhiro;
- Ihara, Takeshi;
- Ikezaki, Hiroaki;
- Hayashi, Takeo;
- Koga, Tsunehisa;
- Kainuma, Mosaburo;
- Hayashi, Jun
Publication type:
journal article
Serum pepsinogen and Helicobacter pylori infection-a Japanese population study.
Published in:
European Journal of Clinical Microbiology & Infectious Diseases, 2012, v. 31, n. 9, p. 2117, doi. 10.1007/s10096-011-1543-0
By:
- Toyoda, K.;
- Furusyo, N.;
- Ihara, T.;
- Ikezaki, H.;
- Urita, Y.;
- Hayashi, J.
Publication type:
Article
Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).
Published in:
Diabetologia, 2011, v. 54, n. 12, p. 3028, doi. 10.1007/s00125-011-2310-6
By:
- Furusyo, N.;
- Koga, T.;
- Ai, M.;
- Otokozawa, S.;
- Kohzuma, T.;
- Ikezaki, H.;
- Schaefer, E.;
- Hayashi, J.
Publication type:
Article
Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure.
Published in:
Journal of Viral Hepatitis, 2015, v. 22, n. 12, p. 992, doi. 10.1111/jvh.12427
By:
- Ogawa, E.;
- Furusyo, N.;
- Dohmen, K.;
- Kajiwara, E.;
- Kawano, A.;
- Nomura, H.;
- Takahashi, K.;
- Satoh, T.;
- Azuma, K.;
- Nakamuta, M.;
- Koyanagi, T.;
- Kotoh, K.;
- Shimoda, S.;
- Hayashi, J.
Publication type:
Article
Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 550, doi. 10.1111/apt.14507
By:
- Ji, F.;
- Wei, B.;
- Yeo, Y. H.;
- Ogawa, E.;
- Zou, B.;
- Stave, C. D.;
- Li, Z.;
- Dang, S.;
- Furusyo, N.;
- Cheung, R. C.;
- Nguyen, M. H.
Publication type:
Article
Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 1, p. 104, doi. 10.1111/apt.14380
By:
- Ogawa, E.;
- Furusyo, N.;
- Nomura, H.;
- Dohmen, K.;
- Higashi, N.;
- Takahashi, K.;
- Kawano, A.;
- Azuma, K.;
- Satoh, T.;
- Nakamuta, M.;
- Koyanagi, T.;
- Kato, M.;
- Shimoda, S.;
- Kajiwara, E.;
- Hayashi, J.;
- The Kyushu University Liver Disease Study (KULDS) Group
Publication type:
Article
Serum WFA<sup>+</sup>-M2 BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C.
Published in:
Alimentary Pharmacology & Therapeutics, 2016, v. 43, n. 1, p. 114, doi. 10.1111/apt.13431
By:
- Ura, K.;
- Furusyo, N.;
- Ogawa, E.;
- Hayashi, T.;
- Mukae, H.;
- Shimizu, M.;
- Toyoda, K.;
- Murata, M.;
- Hayashi, J.
Publication type:
Article
Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis? Authors' reply.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 11/12, p. 1408, doi. 10.1111/apt.12539
By:
- Ogawa, E.;
- Furusyo, N.;
- Hayashi, J.
Publication type:
Article
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study.
Published in:
Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 9, p. 1076, doi. 10.1111/apt.12494
By:
- Ogawa, E.;
- Furusyo, N.;
- Nakamuta, M.;
- Kajiwara, E.;
- Nomura, H.;
- Dohmen, K.;
- Takahashi, K.;
- Satoh, T.;
- Azuma, K.;
- Kawano, A.;
- Tanabe, Y.;
- Kotoh, K.;
- Shimoda, S.;
- Hayashi, J.
Publication type:
Article
Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia.
Published in:
Journal of Viral Hepatitis, 2013, v. 20, n. 12, p. 838, doi. 10.1111/jvh.12109
By:
- Ogawa, E.;
- Furusyo, N.;
- Murata, M.;
- Ikezaki, H.;
- Ihara, T.;
- Hayashi, T.;
- Toyoda, K.;
- Okada, K.;
- Kainuma, M.;
- Kajiwara, E.;
- Takahashi, K.;
- Satoh, T.;
- Hayashi, J.
Publication type:
Article

Found: 10